NLARx Newsletter Header
NLARx News
 February 25, 2010
In This Issue
NLARx News
In the States
Outrage of the Week
Health Reform
Psychiatric Meds
Trade
Fraud & Abuse
Conflicts of Interest
Advertising & Marketing
PBM Watch
Pharma Watch
Patents & Generics
Medicare & Medicaid
Safety & Clinical Trials
Quick Links
Join Our Mailing List
NLARx News
NLARx winter meeting Friday in Washington DC - State legislation, Federal Rx and PBM reform; GAO price report; trade policy and state Medicaid costs, kids and psychotropics.  Details
NLARx Testimony on H.R. 4489, "The Federal Employees Health Benefit Program Prescription Drug Integrity, Transparency and Cost Savings Act" more
In Comments Submitted February 16, NLARx Working Group on Trade Warns USTR Trade Policies Threaten State-Level Drug Price Negotiation and Medicaid Programs more
In the States
Mississippi - Gov. Barbour Signs Bill Restricting Some Cold Medicine more
Florida - Miami Serves As Model In Medicare Fraud Crackdown more
Avandia - Outrage of the Week
Avandia: What Should Patients Do? more
The Secret Glaxo Tape Recording By Steve Nissen more
A Forbes Guest Blogger And His Pharma Ties more
Glaxo Consistently Shared Avandia Data, Except... more
Steve Nissen to GSK (and FDA): "Put Patients First! It's Time to Pull Avandia from the Market." more
Avandia, Heart Attacks & An Internal FDA Battle more
Glaxo Backs Avandia's Safety, Says U.S. Report Biased more
A Face-Off on the Safety of a Drug for Diabetes more
Pharmaceuticals & Health Reform
Sunshine Rules, Rx "Doughnut Hole" In White House Health Care Bill more
Study Finds Nearly A Quarter Of Prescriptions Go Unfilled more
NPR: More Details on the Obama-PhRMA Back Room Deal more
State Lawmakers Address 'Troubling Trends' In Insurance Market more
Insurance Rates Soar In Various States more
EU Pricing Litigation - A Can of Worms - in PharmaGossip's Opinion! more
White House Health Proposal May Blow Up PhRMA Deal more
Psychiatric Meds and Diagnosis
BMJ-Review of the Week more
Physicians: Don't Advertise Medications to Treat Mental Illness more
J&J, Risperdal & Dementia: A Smoking Gun? more
AstraZeneca Faces First Jury Trial Over Seroquel more
Trade
NLARx Notice of Intent to Testify and Summary of Testimony Concerning the 2010 Special 301 Review more
Fraud and Abuse
Novartis-Nitroglycerin SR: Another Whistleblower Case Settled more
Former Pfizer Exec Sues Over Lipitor Marketing more
Medical Center Owner Who Recruited Patients From Skid Row Gets 3 Years in Prison more
Conflicts of Interest
Internal Medicine Residencies and Pharma Money: We Don't Like It but We Take It more
Clout of Drug Industry Seen In MD Residency Programs And In Health Reform more
Advertising and Marketing
Academic Detailing Moves Ahead at State, Federal Level more
Lawsuit Hits Marketing by Medtronic more
Geez, GSK! Find Another Source of "Balanced" Commentary more
A Forbes Guest Blogger And His Pharma Ties more
A New Prescription for Marketing Drugs more
A Snarky Look at Sneaky Marketing Tactics Pharma Hasn't Avoided more
Federal Court Permits Private Lawsuit Seeking to Block Unapproved Drugs to Proceed more
Allergan's Migraine Botox Study: Freedom of Expression or Off-Label Promo Tool? more
A Can of Worms - in PharmaGossip's Opinion! more
Pharma Turns to Tech for Marketing Aid more
PBM Watch
Poll Finds Federal Health Plan Participants Overwhelmingly Support Legislation to Reduce Rx Drug Costs in FEHBP more
Medco CEO: Co Is Industry's Largest Market-Share Gainer more
Medco 4Q Profit Rises 24% As Company Sees Record Revenue more
Hearing on H.R. 4489 - Prescription Drug Integrity, Transparency, and Cost Savings Act more
Express Scripts Turning Prescription Discount Business Into Nonprofit more
Pharma Watch
Grassley Probes WebMd Ties To Eli Lilly more
Whither The Lobby? Tauzin Resigns From PhRMA more
The World's Most Expensive Drugs more
Pfizer Must Pay $9.45 Million in Damages Over Prempro more
Paxil Birth Defect Litigation- First Trial a Bust for GSK more
Roche To Pay $25M Over Accutane And Bowel Disease more
Merck KGaA Swings to Profit, Cuts Dividend more
Patents and Generics
The Obama Plan, Day 2: Pay for Delay, Biologics, CBO Score more
Generics Face Longer Wait for Approval more
GSK's Advair Up For Dispute In Germany more
Drug Firms Apply Brand to Generics more
China Amends Patent Law For Compulsory Licensing more
Indian CEO: 'U.S. Would Grant a Patent to a Piece of Toilet Paper' more
Medicare and Medicaid
Recession Swells Medicaid Rolls, Shrinks State Treasuries more
Medicare Advantage Premiums Jump 14 Percent more
States Consider Medicaid Cuts as Use Grows more
Medicaid Costs Still Leaving States in Deep Debt more
Safety and Clinical Trials
FDA Announces a New Class-Wide REMS more
Pfizer-Trovan: An Editorial more
Will Congress Fund Increased FDA Inspections? more
FDA May Drop Medical Device 'Fast Track' Amid Overuse Concerns more